MMP-1 drives immunopathology in human tuberculosis and transgenic mice.

PubWeight™: 1.77‹?› | Rank: Top 3%

🔗 View Article (PMC 3083790)

Published in J Clin Invest on April 25, 2011

Authors

Paul Elkington1, Takayuki Shiomi, Ronan Breen, Robert K Nuttall, Cesar Augusto Ugarte-Gil, Naomi F Walker, Luísa Saraiva, Bernadette Pedersen, Francesco Mauri, Marc Lipman, Dylan R Edwards, Brian D Robertson, Jeanine D'Armiento, Jon S Friedland

Author Affiliations

1: Department of Infectious Diseases and Immunity, Imperial College London, London, UK. p.elkington@imperial.ac.uk

Articles citing this

Platelets direct monocyte differentiation into epithelioid-like multinucleated giant foam cells with suppressive capacity upon mycobacterial stimulation. J Infect Dis (2014) 2.69

The immunological life cycle of tuberculosis. Nat Rev Immunol (2012) 2.25

Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One (2012) 1.30

Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. Am J Respir Crit Care Med (2014) 1.29

Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases. Am J Respir Crit Care Med (2012) 1.08

Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis. PLoS One (2013) 1.07

Macrophages in tuberculosis: friend or foe. Semin Immunopathol (2013) 1.04

Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol Mol Biol Rev (2013) 0.97

Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children. Clin Vaccine Immunol (2013) 0.97

HIV-1 and the immune response to TB. Future Virol (2013) 0.97

HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome. Semin Immunopathol (2015) 0.97

Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis. PLoS Pathog (2015) 0.96

Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosis. J Infect Dis (2013) 0.95

The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts. Clin Infect Dis (2013) 0.94

The Extracellular Matrix Regulates Granuloma Necrosis in Tuberculosis. J Infect Dis (2015) 0.94

Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation. J Pathol (2014) 0.92

Protection versus pathology in tuberculosis: recent insights. Curr Opin Immunol (2012) 0.92

Anti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIV. Scientifica (Cairo) (2014) 0.92

Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin Immunopathol (2015) 0.92

Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies. Semin Immunopathol (2015) 0.91

Comparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients. Hum Immunol (2012) 0.91

MMPs in tuberculosis: granuloma creators and tissue destroyers. J Clin Invest (2011) 0.91

Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur J Immunol (2013) 0.91

Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity. Chest (2014) 0.90

Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review. Semin Immunopathol (2015) 0.90

Simultaneous immunization against tuberculosis. PLoS One (2011) 0.90

Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans. PLoS One (2012) 0.88

Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis. J Immunol (2015) 0.87

Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model. EBioMedicine (2016) 0.85

Urinary tuberculosis is associated with the development of urothelial carcinoma but not renal cell carcinoma: a nationwide cohort study in Taiwan. Br J Cancer (2013) 0.85

HIV-1 infection of macrophages dysregulates innate immune responses to Mycobacterium tuberculosis by inhibition of interleukin-10. J Infect Dis (2013) 0.84

In vivo prediction of tuberculosis-associated cavity formation in rabbits. J Infect Dis (2014) 0.84

Host gene-encoded severe lung TB: from genes to the potential pathways. Genes Immun (2012) 0.83

Permutations of time and place in tuberculosis. Lancet Infect Dis (2015) 0.83

Mycobacterial trehalose dimycolate reprograms macrophage global gene expression and activates matrix metalloproteinases. Infect Immun (2012) 0.83

Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16(+) monocyte population via the IL-10/STAT3 axis. Cell Res (2015) 0.83

Association of MMP7 -181A→G Promoter Polymorphism with Gastric Cancer Risk: INFLUENCE OF NICOTINE IN DIFFERENTIAL ALLELE-SPECIFIC TRANSCRIPTION VIA INCREASED PHOSPHORYLATION OF cAMP-RESPONSE ELEMENT-BINDING PROTEIN (CREB). J Biol Chem (2015) 0.82

Gender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis. PLoS One (2015) 0.82

Membrane Type 1 Matrix Metalloproteinase Regulates Monocyte Migration and Collagen Destruction in Tuberculosis. J Immunol (2015) 0.81

Matrix metalloproteinase-1 polymorphism (-1607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan. PLoS One (2013) 0.81

Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9. Dis Model Mech (2016) 0.81

Matrix Metalloproteinases in Non-Neoplastic Disorders. Int J Mol Sci (2016) 0.81

Tuberculosis: time for a new perspective? J Infect (2013) 0.81

Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis. Antimicrob Agents Chemother (2014) 0.80

Chemokines in tuberculosis: the good, the bad and the ugly. Semin Immunol (2014) 0.80

Early Secretory Antigenic Target-6 Drives Matrix Metalloproteinase-10 Gene Expression and Secretion in Tuberculosis. Am J Respir Cell Mol Biol (2017) 0.80

The Importance of First Impressions: Early Events in Mycobacterium tuberculosis Infection Influence Outcome. MBio (2016) 0.79

Innate Immune Responses after Airway Epithelial Stimulation with Mycobacterium bovis Bacille-Calmette Guérin. PLoS One (2016) 0.78

Mycobacterium tuberculosis Upregulates TNF-α Expression via TLR2/ERK Signaling and Induces MMP-1 and MMP-9 Production in Human Pleural Mesothelial Cells. PLoS One (2015) 0.78

Mmp1a and Mmp1b are not functional orthologs to human MMP1 in cigarette smoke induced lung disease. Exp Toxicol Pathol (2014) 0.78

Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis. FEBS J (2011) 0.78

Manipulation of BCG vaccine: a double-edged sword. Eur J Clin Microbiol Infect Dis (2016) 0.77

Heterologous Matrix Metalloproteinase Gene Promoter Activity Allows In Vivo Real-time Imaging of Bleomycin-Induced Lung Fibrosis in Transiently Transgenized Mice. Front Immunol (2017) 0.77

Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis. J Infect Dis (2015) 0.76

Host-Directed Therapies for Tuberculosis. Cold Spring Harb Perspect Med (2015) 0.76

A bug's life in the granuloma. Semin Immunopathol (2015) 0.76

In an in vitro model of human tuberculosis, monocyte-microglial networks regulate matrix metalloproteinase-1 and -3 gene expression and secretion via a p38 mitogen activated protein kinase-dependent pathway. J Neuroinflammation (2013) 0.76

Postprimary Tuberculosis and Macrophage Necrosis: Is There a Big ConNECtion? MBio (2016) 0.76

The emerging role of gasotransmitters in the pathogenesis of tuberculosis. Nitric Oxide (2016) 0.75

IFNγ-producing CD4(+) T lymphocytes: the double-edged swords in tuberculosis. Clin Transl Med (2017) 0.75

Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy. EBioMedicine (2015) 0.75

Assessment of treatment response in tuberculosis. Expert Rev Respir Med (2016) 0.75

Matrix metalloproteinase collagenolysis in health and disease. Biochim Biophys Acta (2017) 0.75

Mycobacterium tuberculosis subverts negative regulatory pathways in human macrophages to drive immunopathology. PLoS Pathog (2017) 0.75

Epigenetic Regulation of Matrix Metalloproteinase-1 and -3 Expression in Mycobacterium tuberculosis Infection. Front Immunol (2017) 0.75

Monocyte Adhesion, Migration, and Extracellular Matrix Breakdown Is Regulated by Integrin αVβ3 in Mycobacterium tuberculosis Infection. J Immunol (2017) 0.75

Articles cited by this

Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol (2007) 10.17

Cell-mediated immune responses in tuberculosis. Annu Rev Immunol (2009) 5.90

Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol (2002) 5.73

Immunity to tuberculosis. Annu Rev Immunol (2004) 5.60

The population dynamics and control of tuberculosis. Science (2010) 5.08

Who puts the tubercle in tuberculosis? Nat Rev Microbiol (2006) 4.01

Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science (2009) 3.71

Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest (1990) 2.56

Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol (1979) 2.39

Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med (2010) 2.26

Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol (2001) 2.16

Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev (2007) 2.14

Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem (2000) 2.12

Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine (2006) 1.97

Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis (Edinb) (2007) 1.95

Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun (2006) 1.75

Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax (1996) 1.61

Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol (2009) 1.60

Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS One (2010) 1.53

Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. FEBS Lett (2004) 1.48

Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am J Respir Crit Care Med (2005) 1.47

Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog (2008) 1.41

Specificity of the zebrafish host transcriptome response to acute and chronic mycobacterial infection and the role of innate and adaptive immune components. Mol Immunol (2009) 1.35

Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts. Am J Pathol (2009) 1.34

Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J Immunol (2005) 1.25

ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest (2001) 1.24

IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med (1997) 1.23

Animal models of tuberculosis. Eur J Immunol (2009) 1.22

Biochemistry and turnover of lung interstitium. Eur Respir J (1990) 1.16

Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice. J Clin Invest (2010) 1.11

Rapid diagnosis of smear-negative tuberculosis using immunology and microbiology with induced sputum in HIV-infected and uninfected individuals. PLoS One (2007) 1.10

Localizing matrix metalloproteinase activities in the pericellular environment. FEBS J (2010) 1.03

Monocyte-dependent oncostatin M and TNF-alpha synergize to stimulate unopposed matrix metalloproteinase-1/3 secretion from human lung fibroblasts in tuberculosis. Eur J Immunol (2008) 1.00

Matrix metalloproteinase-1 is regulated in tuberculosis by a p38 MAPK-dependent, p-aminosalicylic acid-sensitive signaling cascade. J Immunol (2009) 0.96

Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis. Rheumatology (Oxford) (2001) 0.95

Liquefaction and cavity formation in pulmonary TB: a simple method in rabbit skin to test inhibitors. Tuberculosis (Edinb) (2009) 0.94

Articles by these authors

QUANTUM ESPRESSO: a modular and open-source software project for quantum simulations of materials. J Phys Condens Matter (2009) 14.22

Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med (2006) 8.39

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26

Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science (2002) 4.49

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis (2013) 4.26

Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci (2002) 4.23

The ADAMTS metalloproteinases. Biochem J (2005) 3.95

Natural ventilation for the prevention of airborne contagion. PLoS Med (2007) 3.73

Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37

Tuberculosis: a problem with persistence. Nat Rev Microbiol (2003) 3.17

Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum (2004) 3.00

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89

Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J (2001) 2.79

Breakdown of the adiabatic Born-Oppenheimer approximation in graphene. Nat Mater (2007) 2.61

The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol (2007) 2.49

The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model. Clin Infect Dis (2007) 2.28

Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis (2013) 2.16

Tetracycline-inducible gene regulation in mycobacteria. Nucleic Acids Res (2005) 2.12

Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis (2010) 2.11

The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med (2008) 2.08

Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab (2011) 2.06

Charge-density wave and superconducting dome in TiSe2 from electron-phonon interaction. Phys Rev Lett (2011) 2.06

The role of chondrocyte senescence in osteoarthritis. Aging Cell (2002) 2.06

Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. J Am Acad Dermatol (2002) 2.05

Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy. J Infect Dis (2009) 2.04

Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med (2006) 2.03

Charging failed asylum seekers for health care in the UK. Lancet (2005) 1.98

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92

Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS One (2013) 1.86

Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology (2006) 1.81

Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res (2005) 1.77

Extracellular regulated kinase/mitogen activated protein kinase is up-regulated in pulmonary emphysema and mediates matrix metalloproteinase-1 induction by cigarette smoke. J Biol Chem (2004) 1.75

Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One (2010) 1.75

Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction. J Am Coll Cardiol (2011) 1.73

Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J Biol Chem (2002) 1.73

Mycobacterial lineages causing pulmonary and extrapulmonary tuberculosis, Ethiopia. Emerg Infect Dis (2013) 1.72

Mycobacterial mutants with defective control of phagosomal acidification. PLoS Pathog (2005) 1.71

The burden of mycobacterial disease in ethiopian cattle: implications for public health. PLoS One (2009) 1.70

Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction. J Mol Cell Cardiol (2012) 1.69

Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J Cell Sci (2002) 1.69

Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLoS One (2012) 1.68

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain (2003) 1.67

HMGA2 is a driver of tumor metastasis. Cancer Res (2013) 1.66

Tuberculosis in primary care. Br J Gen Pract (2002) 1.65

Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med (2009) 1.64

The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J Am Coll Cardiol (2007) 1.63

Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer (2005) 1.63

Influence of CoreValve ReValving System implantation on mitral valve function: an echocardiographic study in selected patients. Catheter Cardiovasc Interv (2011) 1.61

Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today (2006) 1.61

Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol (2008) 1.60

Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clin Infect Dis (2010) 1.60

Impact on and use of health services by international migrants: questionnaire survey of inner city London A&E attenders. BMC Health Serv Res (2006) 1.59

Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res (2008) 1.57

Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res (2003) 1.50

Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. FEBS Lett (2004) 1.48

Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum (2006) 1.48

Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol (2009) 1.48

Structural emphysema does not correlate with lung compliance: lessons from the mouse smoking model. Exp Lung Res (2005) 1.48

Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am J Respir Crit Care Med (2005) 1.47

The OtsAB pathway is essential for trehalose biosynthesis in Mycobacterium tuberculosis. J Biol Chem (2005) 1.47

Unusual features of the cell cycle in mycobacteria: polar-restricted growth and the snapping-model of cell division. Tuberculosis (Edinb) (2007) 1.46

Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens. Int J Tuberc Lung Dis (2011) 1.46

Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res (2004) 1.46

Tuberculous pericardial effusion after coronary artery bypass graft. Ann Thorac Surg (2006) 1.45

The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1. J Biol Chem (2003) 1.45

Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters. PLoS One (2010) 1.44

Nonmalignant respiratory effects of chronic arsenic exposure from drinking water among never-smokers in Bangladesh. Environ Health Perspect (2008) 1.44

Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. Am J Physiol Lung Cell Mol Physiol (2008) 1.43

Tuberculosis in the UK--time to regain control. BMJ (2011) 1.43

The changing pattern of bronchoscopy in an HIV-infected population. Chest (2002) 1.42

Progressive adult-onset emphysema in transgenic mice expressing human MMP-1 in the lung. Am J Physiol Lung Cell Mol Physiol (2003) 1.42

Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol (2003) 1.42

Limited added value of T-SPOT.TB blood test in diagnosing active TB: a prospective bayesian analysis. J Infect (2011) 1.41

Assessment of mitral prosthetic valve thrombosis by live three-dimensional echocardiography: comparison with transesophageal echocardiography. Heart Vessels (2007) 1.40

MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. Am J Pathol (2009) 1.40

Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging (2009) 1.39

The use of abdominal binders to treat over-shunting headaches. J Neurosurg Pediatr (2012) 1.39

Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther (2005) 1.37

Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis (2006) 1.35

An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci (2003) 1.34

Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol (2004) 1.32

Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology (2005) 1.31

Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks. J Immunol (2003) 1.30

Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. Am J Respir Crit Care Med (2014) 1.29

Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circ Res (2005) 1.29

Matrix metalloproteinases: protective roles in cancer. J Cell Mol Med (2011) 1.29

Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int (2010) 1.29

Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res (2009) 1.28

Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting. Diagn Microbiol Infect Dis (2006) 1.26

Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J Immunol (2005) 1.25

Phonon anharmonicities in graphite and graphene. Phys Rev Lett (2007) 1.24